Taylor, Andrew <br/><br/>
A 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function.  [electronic resource] 

 -  Urology  Dec 2010 
 - 1512-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/j.urology.2010.03.066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Creatinine--blood<br/>Humans<br/>Kidney--diagnostic imaging<br/>Kidney Function Tests--methods<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Radionuclide Imaging<br/>Radiopharmaceuticals--pharmacokinetics<br/>Reproducibility of Results<br/>Technetium Tc 99m Mertiatide--pharmacokinetics<br/>Ureteral Obstruction--diagnostic imaging